Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
International Clinical Psychopharmacology|July 1, 1986
Visual hallucinations due to indomethacin: a case reportL E Braddock, R N HeardStudies in History and Philosophy of Biological and Biomedical Sciences|September 19, 2006
Psychoanalysis as functionalist social science: the legacy of Freud's 'Project for a scientific psychology'L E BraddockThe Medical Journal of Australia|May 17, 1993
New horizons in the treatment of multiple sclerosisR N HeardThe British Journal of Psychiatry : the Journal of Mental Science|November 1, 1981
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH testL E Braddock, I M BlakePsychopharmacology|January 1, 1984
The effect of amitriptyline treatment on the growth hormone response to apomorphineP J Cowen, L E Braddock, B GosdenImmunogenetics|January 1, 1989
An epitope on C4 beta light (L) chains detected by human anti-Rg; its relationship with beta chain polymorphism and MHC associationsT Robson, R N Heard, C M GilesBritish Journal of Clinical Pharmacology|June 1, 1985
Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmissionP J Cowen, A R Green, D G Grahame-Smith, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patientsM M Buhler, B H Bennetts, R N Heard, et al.Journal of Neuroimmunology|June 1, 1995
TAP2 polymorphisms in Australian multiple sclerosis patientsB H Bennetts, S M Teutsch, R N Heard, et al.European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|April 1, 1997
HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patientsG J Stewart, S M Teutsch, M Castle, et al.Pageof 2